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The myristoylated alanine-rich C kinase substrate (MARCKS) undergoes a rapid and, in certain circumstances, transient i crease in phosphoryl- 
ation in response to stimuli that activate protein kinase C. We have investigated heprotein-serine/threonine phosphatase ctivity responsible for 
reversing the phosphorylation of MARCKS. In cell-free assays, protein phosphatases 1,2A and 2C (PPl , PP2A and PP2C) all dephosphorylate 
recombinant MARCKS or a synthetic peptide based on its phosphorylation site domain. In intact Swiss 3T3 cells, okadaic acid, a specific inhibitor 
of PPI and PP2A, had little effect on MARCKS phosphorylation on its own, but largely prevented the dephosphorylation ofMARCKS that occured 
following activation of protein kinase C by bombesin with subsequent receptor blockade. These results indicate that although the dephosphorylation 
of MARCKS can be mediated by PP2C in vitro, this protein is dephosphorylated by okadaic acid-sensitive phosphatases in the intact cell. 
MARCKS; Okadaic acid; Protein kinase C, Protein phosphatase 
1. INTRODUCTION 
A major and apparently specific intracellular sub- 
strate for protein kinase C is a 30 kDa protein known 
as the myristoylated alanine-rich C kinase substrate 
(MARCKS) ([l]; see [2,3) for review). MARCKS is 
phosphorylated rapidly when cells are treated with 
hormones, phorbol esters or diacylglycerols that acti- 
vate protein kinase C. It does not appear to be 
phospho~lated to a biolo~cally relevant extent by a 
number of other protein kinases [4,5j, and its phospho- 
rylation has frequently been used as a marker for pro- 
tein kmase C activition in intact cells [2,3]. Although the 
cellular functions of MARCKS and its homologue, the 
MARCKS-related protein (MRP; also known as F52 
and MacMARCKS), are not known, its phosphoryla- 
tion state clearly alters some of its biochemical attrib- 
utes. For example, phosphorylation markedly reduces 
its affinity for calmodulin [6], actin [7], and possibly 
cellular and synthetic membranes [8,9]. The hormone- 
stimulated phospho~lation of MARCKS is dynamic 
and transient in certain ~rc~stan~s, indicating that 
phosphatase activity towards MARCKS is present in 
cells and could regulate the phosphorylation state of the 
protein [lo]. However, the protein phosphatase(s) that 
acts on MARCKS has not been identified. MARCKS 
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does not contain tyrosines in its primary sequence (nor 
does MRP); therefore tyrosine phosphatases are not 
relevant. 
Studies on the activity of protein-serine/threonine 
phosphatases in intact cells and cellular extracts have 
been greatly facilitated by the discovery of highly spe- 
cific inhibitors, such as okadaic acid [ 1 l-l 31. This com- 
plex fatty acid polyketal is an inhibitor of the protein- 
serinelthreonine phospatases termed protein phosphat- 
ase 1 (PPl) and protein phosphate 2A (PPZA), inhib- 
iting PP2A much more potently in cell-free assays [141. 
In combination with other criteria, okadaic acid can be 
used to distinguish the activities of PPl, PP2A and 
PP2C in cellular extracts [14,15]. It is also cell mem- 
brane permeable, allowing investigation of the roles of 
PPl and PP2A in specific processes in intact cells 
[ 12,161. Okadaic acid, like the phorbol esters which acti- 
vate protein kinase C, is a potent tumour promoter [ 171. 
Indeed, it has been suggested that its tumour promoting 
activity may be due, at least in part, to the inhibition of 
dephospho~lation of protein kinase C substrates [13]. 
In this study we have examined the activity of protein 
phosphatases towards the sites on the MARCKS pro- 
tein phosphorylated by protein kinase C. We have used 
the intact protein and also a synthetic peptide contain- 
ing the 3 or 4 sites phosphorylated by protein kinase C 
[18]. We find that both okadaic acid-sensitive and 
-insensitive phosphatases can dephosphorylate these 
phosphorylation sites in cell-free assays, but the 
dephosphorylation of MARCKS is largely prevented by 
okadaic acid in intact cells. 
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2. MATERIALS AND METHODS 
2.1. Materials 
Recombinant MARCKS was expressed in Escherichia coli and pu- 
rified as described in [19]. The synthesis and purification of a 25 ammo 
acid peptide (KKKKKRFSFKKSFKLSGFSFKKNKK) corre- 
sponding to the phosphorylation site domain (PSD) of MARCKS [18] 
was as previously described [6]. The catalytic subunits of PPl and 
PPZA were purified from rabbit skeletal muscle by D. Schelling, S. 
Dale and P. Dent, and inhibitor-2 by Drs. C. Holmes and M. Hubbard 
(at Dundee) [20]. Okadaic acid was a generous gift from Dr. Y. Tsu- 
kitani, Fujisawa Chemical Co., Japan or purchased from LC Services 
Corp., Wobum, MA, USA. Protein kinase C (a mixture of rat brain 
isozymes) was generously donated by Dr. P. Parker, ICRF, London. 
P81 phosphocellulose paper was purchased from Whatman and Se- 
phadex G-25 and G-50 from Pharmacia, Milton Keynes, UK. 
Phosphatidylserine was from Lipid Products, Surrey, UK. Tetrade- 
canoyl phorbol acetate (TPA, otherwise known as PMA) was from 
Sigma, Poole, UK. Bombesin was from Peninsula Labs., Belmont, 
OA, USA; (D-Arg’, D-Pro’, D-Trp’,‘, Leu”) substance P (RPW-sub- 
stance P) was from Calbiochem, LaJolla, CA, USA. Other chemicals 
were from BDH, Poole, UK. 
2.2. Preparation ofphosphorylated MARCKSprotein and PSD peptid. 
MARCKS protein (l-3 PM) or PSD peptide (20 PM) were 
phosphorylated at 30°C in incubations which contained 25 mM Na- 
HEPES (pH 7.5). 0.025% 2-mercaptoethanol, 2.5 mM MgCl,, 0.1 mM 
[Y-~~P]ATP (2-5 x lo5 cpm/nmol by Cerenkov counting), 1 mM CaCl,, 
1.25 mg/ml phosphatidylserine, 1.25 @ml TPA, 0.25% (v/v) Triton 
X-100. Phosphatidylserine, TPA and Triton X-100 were added as 
mixed micelles [21]. After 60 min, EDTA and NaF were added to 5 
mM and 25 mM, respectively. Incorporation of phosphate was as- 
sessed by removing aliquots for precipitation by trichloroacetic acid 
(MARCKS protein) or spotting onto phosphocellulose paper (pep- 
tide) and was 2-3 mol phosphate/m01 of protein or peptide. MARCKS 
protein or PSD peptide were separated from ATP by gel filtration on 
Sephadexes G-50 or G-25, respectively, previously equilibriated with 
50 mM Na-HEPES (pH 7.2), 1 mM EGTA, 1 mM EDTA, 0.05% (v/v) 
2-mercaptoethanol, 0.02% (w/v) Brij-35. The concentrations of 
phosphorylated MARCKS protein and peptide were determined using 
their specific radioactivities. 
2.3. Protein phosphatase assays 
MARCKS phosphatase assays were carried out in duplicate using 
the procedures established for other phosphatase substrates [20], stop- 
ping the reactions with trichloroacetic acid precipitation of the protein 
and measuring phosphatase activity by scintillation counting of the 
released radioactive phosphate. When the PSD peptide was used, 
reactions were stopped by the addition of sulphuric acid, followed by 
extraction of the phosphate molybdate complex in isobutanoliheptane 
(1:l) [20]. Except in the experiment shown in Fig. 1, the degree of 
dephosphorylation was below 30% and was linear with respect o time 
and phosphatase concentration. One unit of activity catalyses the 
release of 1 pmol of phosphate in 1 min. 
2.4. Dephosphorylation of MARCKS in intact cells 
These studies used a modification of the paradigm of Rodriguez- 
Pena et al. [lo]. Briefly, contluent Swiss 3T3 cells were incubated for 
1618 h in serum-free medium to make them quiescent. They were 
then washed and incubated for 2 h in a Krebs-Ringer bicarbonate 
medium containing 0.2 mCi/ml 32P, and 1% (w/v) bovine serum albu- 
min, as described previously [22]. After 1.5 h, okadaic acid, previously 
prepared as a stock solution at 1 mM in dimethyl sulfoxide (DMSO), 
was added to the medium in 111,000 vol. to give a final concentration 
of 1 PM. In controls, DMSO alone was added so that final DMSO 
concentrations in both cases were 0.1% (v/v). After an additional 0.5 
h, the cells were treated with bombesin (3 nM); 1 or 2 min later, they 
were treated with the bombesin antagonist, RPW-substance P (100 
PM). 
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The cells were washed and harvested at various times, and then used 
for the immunoprecipitation of [3zP]MARCKS, as described in [23]. 
In these studies, cellular homogenates were normal&d for trichlo- 
roacetic acid precipitable radioactivity before being subjected to im- 
munoprecipitation. 
3. RESULTS 
3.1. Dephosphorylation of MARCKS by puriJied cata- 
lytic subunits of PPl and PP2A 
MARCKS protein, phosphorylated to a high degree 
of stoichiometry using protein kinase C, could be al- 
most completely dephosphorylated by the purified cata- 
lytic subunit of protein phosphatase 2A (PP2Ac). The 
purified catalytic subunit of protein phosphatase- 1 
(PPlc) also dephosphorylated MARCKS, although 
somewhat less efficiently (Fig. 1). Under conditions 
where the degree of dephosphorylation was propor- 
tional to the amount of phosphatase, the relative activ- 
ities of purified PPlc and PP2Ac towards MARCKS 
were compared with activities towards a synthetic pep- 
tide based on the sequence of the phosphorylation site 
domain (PSD) of MARCKS, also phosphorylated using 
protein kinase C, and a well characterised phosphatase 
substrate, glycogen phosphorylase. The relative activi- 
ties of purified PPlc and PP2Ac were similar towards 
glycogen phosphorylase and the PSD peptide. How- 
ever, the intact MARCKS protein was a rather better 
substrate for PP2Ac than PPlc (Table I). Neither pro- 
tein nor peptide appeared to be a significant substrate 
for PP2B, the Ca*‘/calmodulin-activated phosphatase, 
calcineurin (data not shown). 
3.2. Dephosphorylation of MARCKS and PSD peptide 
by native forms of PPl, PP2A and PP2C 
The relative activities of the native forms of PPl, 
PP2A and the Mg*+-dependent protein phosphatase 2C 
(PP2C) towards MARCKS protein, the PSD peptide 
and phosphorylase were assessed using diluted post- 
mitochondrial extracts of rat liver as a source of 
phosphatases (Table II). PPl activity was assessed as 
the proportion inhibited by 0.2 PM inhibitor-2 and 
PP2A as the proportion inhibited by 2 nM okadaic acid. 
Table I 
Relative activities of purified catalytic subunits of PPl and PP2A 
towards glycogen phosphorylase, MARCKS and PSD peptide 
Substrate Concentration PPl activity PPZA activity 
01M) (%) (%) 
Phosphorylase 10 100 100 
MARCKS 3 86 199 
PSD peptide 3 101 107 
Activity values are the means of duplicate assays that agreed within 
f 5% and are expressed relative to phosphorylase phosphatase activ- 
ities which were 1.98 and 1.15 mu/ml for type 1 and 2A phosphatases, 
respectively. 
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Fig. 1. Dephosphorylation of MARCKS by purified catalytic subunits 
of protein phosphatases 1 (PPl, closed circles) and 2A (PPZA, 0). 
Values are the means of duplicate experiments that agreed within 
f lo%, and are expressed as a percentage of the stoichiometry of 
phosphorylation in control incubations lacking phosphatases in which 
no dephosphorylation was observed (indicated by the broken line). 
The initial stoichiometry of phosphorylation was 2 mol phosphate/m01 
protein. MARCKS was used at 3pM, and PPl and PP2A at 10 mu/ml 
assayed using phosphorylase as substrate. 
Both PPl and PP2A are inhibited completely by 1 PM 
okadaic acid, allowing PP2C to be assessed as the Mg*+- 
dependent activity in the presence of 1 ,uM okadaic acid 
[ 14,151. Total activity was taken as the sum of the activ- 
ities of PPl, PP2A and PP2C. Similar to previous re- 
ports [24,25], just over half (58%) of the total 
phosphorylase phosphatase activity corresponded to 
PPl , and essentially all of the remaining phosphorylase 
phosphatase activity in the absence of divalent metal 
cations was accounted for by PP2A (37% of total). 
PP2C accounted for c 5% of the total phosphorylase 
phosphatase activity. Using the MARCKS protein as 
substrate, PP2A accounted for the greatest proportion 
of the total activity (52%), while PPl was rather less 
active (21% of total). In contrast to phosphorylase 
phosphatase activity, a significant proportion of the 
total activity against MARCKS was accounted for by 
PP2C (27%). In assays performed using two different 
concentrations of the PSD peptide, PPl, PP2A and 
PP2C were all active, but PPl accounted for a greater 
proportion of the total activity in the extracts (42% and 
33% at 10 ,uM and 3 ,uM peptide, respectively) than 
when the MARCKS protein was used as substrate. This 
indicates that the PSD peptide is a better substrate than 
the intact protein for the native forms of PPl in rat liver, 
consistent with results obtained using the purified phos- 
phatase catalytic subunit (Table I). PP2C accounted for 
27% of the total activity when assayed using 10pM PSD 
peptide and 49% using 3 ,uM PSD peptide. 
3.3. Effect of okadaic acid on the phosphorylation and 
dephosphorylation f MARCKS in intact cells 
Rodriguez-Pena et al. [lo] previously showed that, in 
Swiss 3T3 cells, bombesin-stimulated MARCKS phos- 
phorylation rapidly decreased following the addition of 
a bombesin receptor antagonist. Using a minor modifi- 
cation of the same experimental paradigm, we found 
that pretreatment of cells with okadaic acid (1 ,uM for 
30 min) resulted in only a minor increase in MARCKS 
phosphorylation (Fig. 2a,c). Similarly, there was little 
difference between okadaic acid-treated and untreated 
cells 1 min after bombesin stimulation. However, while 
the cells not treated with okadaic acid exhibited rapid 
MARCKS dephosphorylation after the addition of the 
bombesin receptor antagonist (tlR about 4 min), the 
protein was minimally dephosphorylated during this 
time in the cells pretreated with okadaic acid (Fig. 2a,c). 
The incorporation of 32P, into proteins in the total cellu- 
lar homogenates in this experiment is shown in Fig. 2b. 
Even in the absence of bombesin stimulation (0 time 
point), a large increase in the phosphorylation of many 
proteins was seen with okadaic acid treatment. 
Since the difference in MARCKS phosphorylation 
appeared to be greatest in the later time points in this 
experiment, we repeated the experiment and evaluated 
four plates each of okadaic acid-treated and untreated 
cells 13 min after RPW-substance P treatment. The au- 
toradiograph shown in Fig. 3a clearly demonstrates 
markedly increased phosphorylation of MARCKS in 
the okadaic acid-treated cells. Densitometric evaluation 
of these data (Fig. 3b) revealed about a 3.4-fold increase 
in MARCKS phosphorylation in the okadaic acid- 
treated cells, a difference that was highly statistically 
significant (P < 0.0005 using Student’s t-test). A com- 
parison of the magnitude of this change with the initial 
stimulation of phosphorylation by bombesin (Fig. 2a) 
Table II 
Effect of inhibitor-2, okadaic acid and magnesium ions on phosphory- 
lase phosphatase (Phos-P), MARCKS phosphatase (MARCKS-P) 
and PSD peptide phosphatase (PSDP-P) activities in post-mitochon- 
drial extracts of rat liver 
Additions Phos-P MARCKS-P PSDP-P PSDP-P 
activity activity activity activity 
(8) (8) (%) (%) 
1. None 100 100 100 100 
2. 0.2 PM inhibitor-2 45 71 54 59 
3. 2 nM okadaic acid 65 27 76 78 
4. 1 PM okadaic acid 3 0 1 4 
5. 1 PM okadaic acid 5 38 29 60 
plus 10 mM M$ 
Substrate concentra- 10 3 10 3 
tion @M) 
Assays were carried out at 1:150 dilution of extract. Activity values 
are the means of duplicate assays that agreed within f lo%, and are 
given relative to those measured in the standard assay (EGTA without 
Me) which were: 32.8 mu/ml (phosphorylase phosphatase), 4.8 mu/ 
ml (MARCKS phosphatase), 41.7 mu/ml (10pM PSD peptide phos- 
phatase) and 12.6 mu/ml (3 PM PSD peptide phosphatase). One unit 
of activity catalyses the release of 1 pmol of phosphate in 1 min. 
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suggests that much, if not all, of the cellular MARCKS 
phosphatase activity in these cells was inhibited by oka- 
daic acid. 
4. DISCUSSION 
The present studies have demonstrated that 
phosphorylated recombinant MARCKS and its syn- 
thetic PSD peptide are excellent substrates for the cata- 
lytic subunuts of both of the okadaic acid-sensitive 
a. Immunoprecipitates 
M,XlOl 
196- 
106- 
b. Lysates 
I 
0 2 4 6 8 10 12 
h4inutes 
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phosphatases, PPl and PP2A. In fact, the intact protein 
appears to be superior to glycogen phosphorylase as a 
substrate for PP2A, while the PSD peptide is similar to 
phosphorylase. In cell-free extracts, the native forms of 
PPl and PP2A account for all of the phosphatase activ- 
ity towards MARCKS in the absence of divalent metal 
cations. The difference between the PSD peptide and the 
protein persisted in the experiments using extracts; the 
activities of the native forms of PPl and PP2A towards 
the PSD peptide and glycogen phosphorylase were very 
similar, whereas MARCKS was a relatively better sub- 
strate for PP2A and a somewhat worse one for PPl. 
These differences are noteworthy given the near-identity 
of the kinetic responses of the protein and peptide as 
substrates for protein kinase C [4,19]. They suggest that 
there are determinants on MARCKS outside of the 
immediate primary structure at the phosphorylation 
sites that affect its rate of dephosphorylation by these 
phosphatases. Neither protein nor peptide appeared to 
be a significant substrate for PP2B, the Ca’+/calmod- 
ulin-activated phosphatase, calcineurin. However, both 
were substrates for the okadaic acid-resistant and Mg*+- 
dependent phosphatase, PP2C. In this case, the PSD 
peptide appeared to be superior to the protein as a 
substrate. 
These findings raised the interesting question of 
whether PP2C might represent a significant component 
of the MARCKS dephosphorylating activity in intact 
cells. For this reason, we performed experiments imilar 
to those of Rodriguez-Pena et al. [lo], examining the 
dephosphorylation of MARCKS in Swiss 3T3 cells. The 
results of these studies show clearly that the rapid 
MARCKS dephosphorylation that occurs with bomb- 
esin activation of protein kinase C followed by a bomb- 
esin receptor antagonist can be almost completely pre- 
vented by pretreatment of the cells with 1 ,uM okadaic 
acid. In other words, at least in Swiss 3T3 cells, 
MARCKS dephosphorylation is likely to be mediated 
by PPl and/or PP2A. Distinguishing between these two 
activities in intact cells is more difficult than in cell 
t 
Fig. 2. Effects of okadaic acid on MARCKS dephosphorylation in 
Swiss 3T3 cells. Confluent, serum-deprived Swiss 3T3 cells were la- 
belled with ‘*P, and then pre-treated for 30 min with either okadaic 
acid (1 PM in 0.1% (v/v) DMSO) or 0.1% (v/v) DMSO as a control. 
At time 0, both sets of cells were treated with 100pM RPW-substance 
P. Individual plates of cells were harvested at the indicated times, and 
whole cell lysates were normalised for trichloroacetic acid-precipitable 
radioactivity. These matched extracts were then used for the im- 
munoprecipitation of 32P-labelled MARCKS, indicated by the arrow 
in a. Although MARCKS has a calculated molecular mass of 30 kDa, 
it migrates anomalously at about 80 kDa on denaturing gels. An 
autoradiograph of a gel in which equal volumes of the cell lysate were 
subjected to electrophoresis shown in b, and illustrates the effect of 
okadaic acid. In c is shown a quantitative analysis of the 32P-labelled 
MARCKS protein in a, determined by excising the bands containing 
MARCKS from the gel and subjecting them to scintillation counting. 
‘Substance P’ denotes RPW-substance P. 
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Fig. 3. Okadaic acid causes a silent inhibition of MARCKS 
d~hospho~lation in Swiss 3T3 cells. Serum-deprived, confluent 
Swiss 3T3 cells were treated as in the legend to Fig. 2, except that 
bombesin treatment (3 nM) was for 2 min before the addition of 
RPW-substance P (100 FM) for an additional 13 min. The cells were 
then harvested, and four plates of cells for each treatment (okadaic 
acid and 0.1% (v/v) DMSO control) were matched for trichloroacetic 
acid-precipitable radioactivity and subjected to immunoprecipitation 
with an anti-MARCKS antibody. In a is shown an autoradiograph of 
these data; 32P-labelled MARCKS is indicated by the arrow. In b is 
shown a densitometric evaluation of the extent of MARCKS phos- 
phorylation; the hatched bar indicates the mean ?r S.D. from the four 
plates of cells treated with okadaic acid; the open bar indicates the 
mean & S.D. from the four control plates of cells treated with 0.1% 
(v/v) DMSO alone. 
extracts, but could conceivably be accomplished by the 
use of careful okadaic acid dose-response analyses, 
combined with the use of tautomycin, a toxin more 
potent for PPI than PP2A [26]. 
Several previous studies have evaluated changes in 
MARCKS phosphorylation state with okadaic acid 
treatment of cells, and the results have been somewhat 
conflicting. For example, Mahadevan et al. [27] found 
that okadaic acid did not significantly enhance phorbol 
ester-stim~ated MARCKS phosphorylation in a mouse 
fibroblast cell line. On the other hand, Bhat [28] showed 
that okadaic acid enhanced phorbol ester-stimulated 
MARCKS phosphorylation in oligodenroglial progeni- 
tor cells, while Thelen et al. [8] demonstrated that oka- 
daic acid inhibited MARCKS dephosphorylation in 
fMet-Leu-Phe-stimulated human neutrophils. More re- 
cently, Amess et al. [29] found that okadaic acid ap- 
peared to inhibit MARCKS dephosphorylation from 
one or two (but not three) of its serine phospho~lation 
sites in mouse fibroblasts. Thus, most studies in intact 
cells to date agree that okadaic acid-sensitive 
phosphatases are involved in dephospho~lation of at 
least some phosphorylated serines in MARCKS in in- 
tact cells. Such phosphatases eem to be important in 
controlling the phosphorylation state of MARCKS 
during the recovery period after the transient activation 
of protein kinase C. However, our results also suggest 
that under basal conditions, at least in Swiss 3T3 cells, 
protein kinase C activity is very low and the phospho- 
rylation state of MARCKS is not greatly influenced by 
the activity of okadaic acid-inhibited phosphatases. 
Fu~he~ore, they indicate that okadaic acid does not 
activate protein kinase C. 
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